Invesco Dynamic Pharmaceuticals ETF Stock Price, News & Analysis (NYSEARCA:PJP)

$57.97
+0.38 (+0.66 %)
(As of 09/20/2019 04:00 PM ET)
Add
Today's Range
$57.73
Now: $57.97
$58.3199
50-Day Range
$55.50
MA: $56.79
$58.30
52-Week Range
$55.27
Now: $57.97
$73.76
Volume10,606 shs
Average Volume34,728 shs
Market Capitalization$373.91 million
P/E RatioN/A
Dividend Yield1.24%
BetaN/A
PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.

Basic Details

Issuer Invesco
Fund NameInvesco Dynamic Pharmaceuticals ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:PJP
Inception Date6/23/2005
Fund ManagerPeter Hubbard, Michael Jeanette, Tony Seisser, Jonathan Nixon
Phone+1-800-9830903

Fund Focus

Asset ClassEquity
BenchmarkDynamic Pharmaceuticals Intellidex Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$374.40 million
Average Daily Volume$26,462.30
Discount/Premium-0.08%

ETF Expenses

Management Fee0.50%
Other Expenses0.06%
Total Expenses0.56%
Fee Waiver0.00%
Net Expenses0.56%

Administrator, Advisor and Custodian

AdministratorThe Bank of New York Mellon Corporation
AdvisorInvesco Capital Management LLC
CustodianThe Bank of New York Mellon Corporation
DistributorInvesco Distributors, Inc.
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerIMC Chicago

Receive PJP News and Ratings via Email

Sign-up to receive the latest news and ratings for PJP and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP)
Currency Exposure of Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP)
Sector Exposure of Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP)
Industry Exposure of Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP)

Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) Frequently Asked Questions

What is Invesco Dynamic Pharmaceuticals ETF's stock symbol?

Invesco Dynamic Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PJP."

How often does Invesco Dynamic Pharmaceuticals ETF pay dividends? What is the dividend yield for Invesco Dynamic Pharmaceuticals ETF?

Invesco Dynamic Pharmaceuticals ETF declared a quarterly dividend on Monday, March 18th. Stockholders of record on Tuesday, March 19th will be paid a dividend of $0.0606 per share on Friday, March 29th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.42%. The ex-dividend date is Monday, March 18th. View Invesco Dynamic Pharmaceuticals ETF's Dividend History.

Has Invesco Dynamic Pharmaceuticals ETF been receiving favorable news coverage?

News articles about PJP stock have trended somewhat negative on Saturday, InfoTrie reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Invesco Dynamic Pharmaceuticals ETF earned a news impact score of -1.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Invesco Dynamic Pharmaceuticals ETF.

What other stocks do shareholders of Invesco Dynamic Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco Dynamic Pharmaceuticals ETF investors own include iShares 20+ Year Treasury Bond ETF (TLT), iShares Russell 2000 ETF (IWM), Akcea Therapeutics (AKCA), iShares Nasdaq Biotechnology ETF (IBB), BOX (BOX), IDT (IDT), Ingredion (INGR), Manitowoc (MTW), OneMain (OMF) and Regions Financial (RF).

Who are Invesco Dynamic Pharmaceuticals ETF's key executives?

Invesco Dynamic Pharmaceuticals ETF's management team includes the folowing people:
  • H. Bruce Bond, Chairman of the Board of Trustee, Chief Executive Officer (Age 49)
  • Bruce T. Duncan, Chief Financial Officer, Treasurer (Age 60)
  • Kevin R. Gustafson, Chief Compliance Officer (Age 43)
  • Keith A Ovitt, Secretary (Age 50)
  • Ronn R. Bagge, Trustee (Age 55)
  • Marc M Kole, Trustee (Age 53)
  • D. Mark McMillan, Trustee (Age 49)
  • Philip M. Nussbaum Mba, Trustee (Age 52)
  • Donald H. Wilson, Trustee (Age 55)

Who are Invesco Dynamic Pharmaceuticals ETF's major shareholders?

Invesco Dynamic Pharmaceuticals ETF's stock is owned by many different of institutional and retail investors. Top institutional investors include Envestnet Asset Management Inc. (2.77%), Peak Asset Management LLC (2.03%), Bank of America Corp DE (1.18%), LPL Financial LLC (1.18%), Morgan Stanley (0.94%) and Commonwealth Equity Services LLC (0.64%).

Which major investors are selling Invesco Dynamic Pharmaceuticals ETF stock?

PJP stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, CIBC Private Wealth Group LLC, Morgan Stanley, LPL Financial LLC, Wells Fargo & Company MN, Advisor Group Inc., Royal Bank of Canada and MML Investors Services LLC.

Which major investors are buying Invesco Dynamic Pharmaceuticals ETF stock?

PJP stock was bought by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., First Allied Advisory Services Inc., Starfire Investment Advisers Inc., Citadel Advisors LLC, Pacific Sun Financial Corp, Ladenburg Thalmann Financial Services Inc., Reilly Financial Advisors LLC and Advisory Services Network LLC.

How do I buy shares of Invesco Dynamic Pharmaceuticals ETF?

Shares of PJP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Invesco Dynamic Pharmaceuticals ETF's stock price today?

One share of PJP stock can currently be purchased for approximately $57.97.

How big of a company is Invesco Dynamic Pharmaceuticals ETF?

Invesco Dynamic Pharmaceuticals ETF has a market capitalization of $373.91 million. View Additional Information About Invesco Dynamic Pharmaceuticals ETF.

What is Invesco Dynamic Pharmaceuticals ETF's official website?

The official website for Invesco Dynamic Pharmaceuticals ETF is http://www.invescopowershares.com/.

How can I contact Invesco Dynamic Pharmaceuticals ETF?

Invesco Dynamic Pharmaceuticals ETF's mailing address is 301 W. Roosevelt Road, Wheaton, 60187, United States. The company can be reached via phone at +1-800-9830903.


MarketBeat Community Rating for Invesco Dynamic Pharmaceuticals ETF (NYSEARCA PJP)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  29 (Vote Outperform)
Underperform Votes:  41 (Vote Underperform)
Total Votes:  70
MarketBeat's community ratings are surveys of what our community members think about Invesco Dynamic Pharmaceuticals ETF and other stocks. Vote "Outperform" if you believe PJP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PJP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/21/2019 by MarketBeat.com Staff

Featured Article: High-Yield Dividend Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel